Autori: von Minckwitz Gunter
| Naslov | Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial (Article) |
| Autori | von Minckwitz Gunter Colleoni Marco A Kolberg Hans-Christian Morales Serafin Santi Patricia Xavier Tomasevic Zorica I Zhang Nan Hanes Vladimir |
| Info | LANCET ONCOLOGY, (2018), vol. 19 br. 7, str. 987-998 |
| Projekat | Amgen |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Clinical comparison of the biosimilar ABP 980 and trastuzumab in early breast cancer: Results of the phase 3 LILAC study and justification for extrapolation across approved trastuzumab indications (Meeting Abstract) |
| Autori | Kolberg Hans-Christian Tomasevic Zoran M Demetriou Georgia S von Minckwitz Gunter Fujiwara Yasuhiro Ponomarova O Tesch Hans Santi Patricia Xavier Hanes Vladimir |
| Info | EUROPEAN JOURNAL OF CANCER, (2018), vol. 92 br. , Suppl. 3, str. S103-S104 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | PIK3CA alterations and benefit with neratinib after trastuzumab-based adjuvant therapy in early-stage HER2+breast cancer: Correlative analyses of the phase III ExteNET trial (Meeting Abstract) |
| Autori | Chia Stephen KL ... Holmes Frankie Ann Ejlertsen Bent Delaloge Suzette Moy Beverly Iwata Hiroji von Minckwitz Gunter Mansi Janine Barrios Carlos H Gnant Michael Evic Zorica Toma Denduluri Neelima Eparovic Robert Kim Sung-Bae Jakobsen Erik Hugger Harvey Vernon Robert Nicholas Smith John II Harker Graydon Lalani Alshad S Zhang Bo Eli Lisa D Buyse Marc (broj koautora 25) |
| Info | CANCER RESEARCH, (2018), vol. 78 br. 4, Suppl. S, str. - |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
